Evidence map›Paper›PMID 35243969›Full record

ArticleJournal of the International Neuropsychological Society : JINS2023

APOE Effects on Late Life Cognitive Trajectories in Diverse Racial/Ethnic Groups.

Michelle L Chan, Oanh L Meyer, Sarah T Farias, Rachel A Whitmer, Kumar Rajan, John Olichney, David Johnson, Dan Mungas

Open access · greenAbstract read
In one paragraph

Article in Journal of the International Neuropsychological Society : JINS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Novel genetic profile linked to cognitive decline in Hispanics/Latinos.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Alcohol use andAlzheimer's & dementia. Behavior & socioeconomics of aging · 2026
    Article
  3. The relationships between ethnoracial identity, Aβ positivity, APOEε4, and medial temporal lobe tau PET.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Apolipoprotein E e4 Status Predicts Memory Performance and Daily Functioning in Aging Hispanic/Latino Adults.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2026
    Article
  6. Life Purpose Lowers Risk for Cognitive Impairment in a United States Population-Based Cohort.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. AD and non-AD mediators of the pathway between the APOE genotype and cognition.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Michelle L ChanDepartment of Neurology, University of California, Davis, USA.ORCID https://orcid.org/0000-0003-3177-241X
Oanh L MeyerDepartment of Neurology, University of California, Davis, USA.
Sarah T FariasDepartment of Neurology, University of California, Davis, USA.
Rachel A WhitmerDepartment of Public Health Sciences, University of California, Davis, USA.
Kumar RajanDepartment of Public Health Sciences, University of California, Davis, USA.
John OlichneyDepartment of Neurology, University of California, Davis, USA.
David JohnsonDepartment of Neurology, University of California, Davis, USA.
Dan MungasDepartment of Neurology, University of California, Davis, USA.ORCID https://orcid.org/0000-0003-2035-7085
University of California, Davis · US

Funding

UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Charles DeCarli, Rachel A Whitmer · 2021 to 2026
$25.2M
Preserving Cognitive Resilience: A Biracial Parent-Offspring Study (18-4674) - Feasibility StudyR01AG058679 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI EVANS, DENIS A, RAJAN, KUMAR B. · 2019 to 2024
$13.8M
Brain pathologies, reserve and cognition in aging and dementiaR01AG031563 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Evan Fletcher, SARAH E TOMASZEWSKI-FARIAS · 2009 to 2026
$8.9M
Heterogeneity of Mild Cognitive Impairment(MCI)R01AG021028 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 2003 to 2014
$4.6M
ENGLISH AND SPANISH ASSESSMENT OF COGNITION IN ELDERLYR01AG010220 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI MUNGAS, DAN M. · 1992 to 2012
$4.5M
Brain pathologies, reserve and cognition in aging and dementiaRF1AG031563 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MUNGAS, DAN M. · 2015 to 2015
$3.8M
Psychometric Integrative Technology for Cognitive Health ResearchR01AG051170 · NIA · BROWN UNIVERSITY · PI JONES, RICHARD N · 2015 to 2019
$3.4M
The impact of non-amyloid processes on cognitive agingR01AG047827 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DECARLI, CHARLES · 2014 to 2018
$2.9M
Understanding the Pathway to Functional Disability in Alzheimer's diseaseR01AG031252 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TOMASZEWSKI-FARIAS, SARAH E · 2008 to 2012
$1.8M
Factors Influencing Decline in AD Trends in a Biracial Population StudyRF1AG057532 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RAJAN, KUMAR B. · 2017 to 2017
$1.7M
Nonlinear Models of Cognition Preceding AD in a Biracial Population SampleR01AG051635 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RAJAN, KUMAR B. · 2016 to 2020
$1.5M
NIA NIH HHS P30 AG010129NIA NIH HHS P30 AG072972NIA NIH HHS R01 AG010220NIA NIH HHS R01 AG021028NIA NIH HHS R01 AG031252NIA NIH HHS R01 AG031563NIA NIH HHS R01 AG047827NIA NIH HHS R01 AG051170NIA NIH HHS R01 AG051635NIA NIH HHS R01 AG058679NIA NIH HHS RF1 AG031563NIA NIH HHS RF1 AG057532
6 · The paper itself

Abstract

objectiveThis study evaluated: (1) apolipoprotein E (APOE) ϵ4 prevalence among Black, Latino, and White older adults, (2) associations of APOE ϵ4 status with baseline level and change over time of cognitive outcomes across groups, and (3) combined impact of APOE ϵ4 prevalence and magnitude of effect on cognitive decline within each racial/ethnic group.

methodParticipants included 297 White, 138 Latino, and 149 Black individuals from the longitudinal UC Davis Diversity Cohort who had APOE genotyping and ≥2 cognitive assessments. Magnitude of associations of ϵ4 with cognitive baseline and change across racial/ethnic groups was tested with multilevel parallel process longitudinal analyses and multiple group models.

resultsϵ4 prevalence in Black (46%) and White participants (46%) was almost double that of Latino participants (24%). ϵ4 was associated with poorer baseline episodic memory only in White participants (

conclusionCalculated cognitive trajectories across racial/ethnic groups were influenced in an additive manner by ϵ4 prevalence and strength of association with cognitive decline within the group. Group differences in ϵ4 prevalences and associations of ϵ4 with cognition may suggest different pathways from APOE to cognitive decline, and, AD possibly having less salient impact on cognitive decline in non-White participants. Differential effects of APOE on episodic memory and non-memory cognition have important implications for understanding how APOE influences late life cognitive decline.

Indexed as

Cognitive DysfunctionEthnicityAgedApolipoprotein E4Apolipoproteins EBlack or African AmericanCognitionHispanic or LatinoHumansWhite PeopleApolipoprotein E4Apolipoproteins EAlzheimer’s diseaseCognitionCognitive agingExecutive functioningMemoryNeuropsychology

Identifiers

PMID35243969
PMCPMC9440953
OpenAlexW4221019717

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.